How many patients might receive thrombolytic therapy in the light of the ECASS-3 and IST-3 data?
Bembenek
Jan
J
Kobayashi
Adam
A
Sandercock
Peter
P
Czlonkowska
Anna
A
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods* / Q000706:statistics & numerical data*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator